SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 14, 2026

JNJ

JOHNSON & JOHNSON
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $29.1M total
Actionable Insight • Neutral

This is a routine insider sale cluster with no material signal. The CEO's concurrent option exercise suggests tax-related or diversification selling rather than a bearish view. Monitor for any acceleration of insider selling, but this alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$262.37
T+0 close · Aug 14, 2026 · via day close
Latest settled
+7.02%
T+60 · $280.78
Vs SPY
+9.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $262.37entry
  2. T+1 · 3mo ago +3.33%α +4.01% · $271.11
  3. T+5 · 3mo ago +4.07%α +5.26% · $273.04
  4. T+20 · 2mo ago +1.84%α +3.82% · $267.20
  5. T+60 · 6d ago +7.02%α +9.96% · $280.78
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

JNJ CEO Joaquin Duato and EVP/Chief Legal Officer Elizabeth Forminard sold a combined $29.11M in open-market shares over a 7-day window. The total sales represent only ~0.005% of JNJ's $627.4B market cap, making this a routine insider transaction cluster with no material signal. Duato concurrently exercised 123,291 stock options at $115.67/share, suggesting tax-related or diversification selling rather than a bearish view on the company.

Key Financial Metrics

Direction
selling
Total Value
$29.1M
Insiders
2

Key Facts

  • CEO Joaquin Duato sold $26.70M in open-market shares on August 13, 2026
  • EVP/Chief Legal Officer Elizabeth Forminard sold $2.41M on August 6, 2026
  • Total insider sales of $29.11M represent only ~0.005% of JNJ's $627.4B market cap
  • Duato also exercised 123,291 stock options at $115.67/share on the same day, indicating a routine exercise-and-sell pattern

Financial Impact

Negligible, $29.11M in insider sales is ~0.005% of JNJ's $627.4B market cap

Market Snapshot

Price
$261.32
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (31 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-JNJ-1786775133082

Track record

21 reports on JNJ

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +13.24% at T+60 after the May 13, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $289.75 Now $282.55 −2.48% settles Feb 12
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $283.52 Now $282.55 −0.34% settles Feb 10
  3. Oct 13, 20264w ago 8-K Mixed 6/10 Entry $248.61 Now $282.55 +13.65% settles Jan 8
  4. Sep 30, 20266w ago Court Ruling Bullish 6/10 Entry $258.66 Now $282.55 +9.24% settles Dec 28
  5. Sep 24, 20267w ago Court Ruling Neutral 3/10 Entry $271.22 Now $282.55 +4.18% settles Dec 21
  6. Sep 9, 20269w ago Court Ruling Neutral 1/10 Entry $266.35 Now $282.55 +6.08% settles Dec 4
  7. Aug 18, 202612w ago Insider Cluster Neutral 2/10 Entry $273.41 to $283.52 Now $282.55 +3.34% ▲ +3.70% +5.25% vs SPY
  8. Aug 14, 202613w ago Insider Cluster Neutral 2/10 Viewing Entry $262.37 to $280.78 Now $282.55 +7.69% ▲ +7.02% +9.96% vs SPY
  9. Aug 7, 202614w ago Insider Cluster Neutral 3/10 Entry $261.81 to $266.17 Now $282.55 +7.92% ▲ +1.67% +4.08% vs SPY
  10. Aug 7, 202614w ago Court Ruling Bearish 4/10 Entry $261.81 to $266.17 Now $282.55 −7.92% ▼ −1.67% −4.08% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 15, 2026